women's health
Nanopath Nabs $3M SBIR Grant for Pelvic, Gynecologic Infection Tests
The National Institutes of Health funding and $1 million awarded in September from the National Science Foundation will support the firm's R&D.
Craig-Hallum Initiates Coverage of Natera With Buy Rating
Analyst Bill Bonello noted growth potential across Natera's markets, along with potential risks related to reimbursement, competition, and profitability.
Natera pointed to expanded Signatera coverage, the upcoming completion of its ALTAIR study, and potential uplift from recent biomarker legislation as future growth drivers.
The firm has updated its low-cost Hub instrument and pivoted its testing menu toward multiplex point-of-care panels.
Natera Acquires Reproductive Health Assets From Invitae for up to $52.5M
As part of the transaction, Invitae will begin transitioning its noninvasive prenatal screening and carrier screening customers to Natera.
Jun 22, 2022
Oct 13, 2020
Enzo Biochem Q4 Revenues Down 7 Percent
Feb 6, 2020
Jan 31, 2020
NeuMoDx T. Vaginalis, M. Genitalium Assay CE Marked
Mar 11, 2019
Enzo Biochem Fiscal Q2 Revenues Sink 26 Percent
Dec 19, 2018
Celmatix Forms Therapeutics Discovery Division
Dec 10, 2018
Enzo Biochem Fiscal Q1 Revenues Down 21 Percent
Nov 27, 2018